In the interview, Gustav Sten talks about his new role, his journey within the company, and reflects on the development under Anders Hultman’s leadership. He also shares his priorities going forward, with a focus on commercialization and continued growth.
Concile Global explores opportunities to expand its POCT portfolio
During a recent visit to KSB Biotech in China, IDL Diagnostics and its German partner concile explored potential additions to Concile Global’s international point-of-care testing portfolio. Discussions focused on biomarkers compatible with the reader platforms already...
